Stem cells to regenerate the heart
https://reachmd.com/programs/clinicians-roundtable/stem-cells-to-regenerate-the-heart/2490/
A treatment that uses adult stem cells to rebuild failing hearts - once believed to be impossible - is making progress helping patients rebound from severe coronary artery disease, a leading killer of people around the world. Dr. Douglas Losordo, head of the program in cardiovascular regenerative me
Adult Stem Cells, Cloning, Gene Therapy
https://reachmd.com/programs/clinicians-roundtable/adult-stem-cells-cloning-gene-therapy/966/
In this segment Dr. Sherley speaks about many stem cell related topics including the relationship between stem cells and cloning, gene therapy and how adult stem cells work.
What triggers stem cells to differentiate?
https://reachmd.com/programs/clinicians-roundtable/what-triggers-stem-cells-to-differentiate/2252/
John A. Kessler MD, Davee Professor of Stem Cell Biology, Chairman, Davee Department of Neurology, Northwestern University Medical School, is one of the world’s leaders in stem cell research to repair central and peripheral nerve damage. He joins us to talk about how growth factors promote neuronal
The Promise of Stem Cells Reaching Patients
https://reachmd.com/programs/clinicians-roundtable/the-promise-of-stem-cells-reaching-patients/2971/
The promise of stem cell research, once deemed a scientists' dream, has turned the corner into real marketed products and looks to soon be a multi-billion-dollar industry. Randal Mills, the chief executive officer of Osiris Therapeutics tells the Chicago Tribune's Bruce Japsen about stem cell produc
The Root of Tooth Regeneration and Stem Cells
https://reachmd.com/programs/clinicians-roundtable/the-root-of-tooth-regeneration-and-stem-cells/2895/
What are the mechanisms behind animal tooth regeneration, and what can tooth stem cell research tell us? Your host, Dr. Bruce Bloom and Dr. Ophir Klein, of the Biomedical Sciences Graduate Program at the University of California, San Francisco discuss stem cell research and the potential clinical ap
Issues in Funding Pluripotent Stem Cell Research
https://reachmd.com/programs/clinicians-roundtable/issues-in-funding-pluripotent-stem-cell-research/4632/
Expanded guidelines for stem cell research have favored federal financing for embryonic stem cell development. But some researchers in the field are looking beyond embryonic stem cells. Ken Aldrich, chief executive officer and co-founder of International Stem Cell Corporation, tells host Bruce Japse
Parsing the Debate Over Embryonic Stem Cells
https://reachmd.com/programs/clinicians-roundtable/parsing-the-debate-over-embryonic-stem-cells/2972/
While politicians debate whether there should be federal funding of embryonic stem cells, they might be over-looking a key point: the fact that all of the momentum in stem cell research is not in cells derived from human embryos at all. Randal Mills, the chief executive officer of Osiris Therapeutic
Developing Lines of RBCs From Stem Cells
https://reachmd.com/programs/focus-on-future-medicine-and-genetics/developing-lines-of-rbcs-from-stem-cells/4137/
Scientists and medical experts hold grand ambitions for the emerging role of human embryonic stem cells in medicine. One of the first gains realized from these cells could be the production of red blood cells for transfusion, though several key obstacles remain. Host Dr. Mark Nolan Hill looks at the
Embryonic stem cell research chances
https://reachmd.com/programs/clinicians-roundtable/embryonic-stem-cell-research-chances/1588/
As political pressure builds on Republicans over the War in Iraq, will Congress finally OK a veto-proof bill to allow federal funding for embryonic stem cell research? Mary Woolley, CEO of Research America says the political climate is improving for a bill to pass and survive a Bush veto for embryon
Real Uses for Stem Cells On the Horizon
https://reachmd.com/programs/clinicians-roundtable/real-uses-for-stem-cells-on-the-horizon/4325/
Stem cells are often seen as potential agents in the field of regenerative medicine. What are the realities and what should doctors expect? Dr. Marc Hedrick, president of San Diego-based Cytori Therapeutics, tells the Chicago Tribune's Bruce Japsen about commercialized treatments already being used,